Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Annals of Hematology|March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndromeGuillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.Blood|June 24, 2016
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemiaRachel E Rau, Benjamin A Rodriguez, Min Luo, et al.Immunity|August 23, 2003
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1Katrin Layer, Guosheng Lin, Alessio Nencioni, et al.Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.Nature|April 9, 2025
Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemiaAleksandra E Kamizela, Daniel Leongamornlert, Nicholas Williams, et al.Journal of Hematology & Oncology|August 29, 2021
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trialFarhad Ravandi, Gail J Roboz, Andrew H Wei, et al.Pageof 4